Rasagiline Genepharm Special Precautions

Advise patients to inform the doctor or pharmacist of the following before taking Rasagiline Genepharm: Liver problems; Any suspicious skin changes. Treatment with rasagiline may possibly increase the risk of skin cancer.
Patients or patients' family/carer must be advised to inform the doctor if they notice that the patient is developing unusual behaviours where the patient cannot resist the impulse, urges or cravings to carry out certain harmful or detrimental activities to themselves or others. These are called impulse control disorders. In patients taking rasagiline and/or other medicines used to treat Parkinson's disease, behaviours such as compulsions, obsessive thoughts, addictive gambling, excessive spending, impulsive behaviour and an abnormally high sex drive or an increase in sexual thoughts or feelings have been observed. The dose may be needed to adjust or stop (see Side Effects).
Rasagiline Genepharm may cause drowsiness and may cause the patient to suddenly fall asleep during day time activities, especially if they are taking other dopaminergic medicinal products (used for the treatment of Parkinson's disease). For further information, refer to Driving and using machines as follows.
Driving and using machines: Patients must be advised before driving and operating machines, since Parkinson's disease itself as well as the treatment with Rasagiline Genepharm may influence the ability to do so. Rasagiline Genepharm can make the patient feel dizzy or drowsy; it can also cause episodes of sudden sleep onset.
This might be enhanced if the patient takes other medicines to treat the symptoms of Parkinson's disease, or if the patient takes medicines that can cause drowsiness, or drink alcohol while taking Rasagiline Genepharm. If the patient had experienced somnolence and/or episodes of sudden sleep onset before, or while taking Rasagiline Genepharm do not drive or operate machinery (see Contraindications).
Use in Children: There is no relevant use of rasagiline in children and adolescents. Therefore, Rasagiline Genepharm is not recommended for use under the age of 18.